3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
2
Prostatic Neoplasms
1
Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Colonic Neoplasms
1
Interventions
Zoledronic Acid
28
Saline Solution
26
Metformin
25
Dexamethasone
25
Cyclophosphamide
23
Cytarabine
22
Bupivacaine
20
Sodium Chloride
18
Vincristine
17
Methotrexate
17
Letrozole
17
Propofol
15
Morphine
15
Doxorubicin
15
Prednisolone
14
Docetaxel
14
Dexmedetomidine
14
Cisplatin
14
Bevacizumab
14
Oxycodone
13
Imiquimod
13
Fentanyl
13
Capecitabine
13
Rituximab
12
Mercaptopurine
12
Fluorouracil
12
Granulocyte Colony-Stimulating Factor
11
Everolimus
11
Asparaginase
11
Acetaminophen
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Completed
×
Isoflurane
×
Clear all
NCT04074460
2022-06-09
VAPOR-C
Peter MacCallum Cancer Centre, Australia
Phase 4
Completed
169 enrolled
NCT00575354
2008-04-21
CSIABTEC
Nanjing Medical University
Phase 4
Completed
500 enrolled